Some Smart Buys STOCK 52-WEEK PRICE* HIGH ADVANCED 10 5/16 14 7/8 Developing a new MAGNETICS cancer drug--with one drug already commercially avail- able CENTOCOR 37 7/16 53 3/4 Its new Crohn's disease drug is slated to do well NPS PHARMACEUTICAL 7 3/4 11 A postmenopausal drug is being devel- oped; Company has a valuable partnership with Amgen PROTEIN DESIGN LABS 25 5/16 51 1/2 A strong pipeline is behind its new kidney drug SYNAPTIC 14 7/8 17 3/8 Obesity and migraine drugs being developed *JUNE 1 DATA: BUSINESS WEEK RELATED ITEMS THE SEARCH FOR VALUE COVER IMAGE: Where to Invest STOCKS TABLE: Big and Cheap CHART: Large-Cap Stocks Lead the Way `I LOVE TO BUY A GROWTH VEHICLE THAT HAS BEEN BEATEN UP' (extended) MERGERS TABLE: Consolidation Plays `IT'S LIKE SHOOTING FISH IN A BARREL' TECHNOLOGY BIOTECH TABLE: Some Smart Buys SHORTS REAL ESTATE GLOBAL BONDS MUTUAL-FUNDS 401(k)s INVESTOR POLL INSIDE WALL STREET: REEBOK INSIDE WALL STREET: GENERAL MILLS INSIDE WALL STREET: ADVANCED HEALTH Return to main story

Updated June 4, 1998 by bwwebmaster
Copyright 1998, by The McGraw-Hill Companies Inc. All rights reserved.
Terms of Use